Macrogenics (MGNX) Treasury Shares (2012 - 2026)

Macrogenics (MGNX) posted quarterly Treasury Shares of $19000.0 for Q1 2015, little changed quarter-over-quarter from $19000.0 in Q4 2014.

Macrogenics (MGNX) Treasury Shares (2012 - 2026) Analysis & Trends

Macrogenics (MGNX) has reported Treasury Shares for 4 consecutive years, with $19000.0 the latest figure, recorded in Q1 2015.

In Q1 2015, Treasury Shares changed N/A year-over-year to $19000.0; the TTM figure through Mar 2015 stood at $19000.0 (changed N/A YoY), while the FY2014 annual figure was $19000.0, down 67.24% from the prior year.
Treasury Shares steadied at $19000.0 in Q1 2015 per MGNX's latest filing, from $19000.0 in the prior quarter.
Across five years, Treasury Shares topped out at $1.1 million in Q1 2024 and bottomed at $307308.0 in Q2 2022.
Historically, Treasury Shares has averaged $824259.1 across 5 years, with a median of $908277.0 in 2023.
Annual changes were most pronounced in 2013 — Treasury Shares climbed 0.45% — and 2014, when it plunged 67.24%.
Macrogenics' Treasury Shares stood at $57742.0 in 2012, then increased by 0.45% to $58000.0 in 2013, then slumped by 67.24% to $19000.0 in 2014, then changed by 0.0% to $19000.0 in 2015.
Business Quant data shows MGNX's Treasury Shares at $19000.0 in Q1 2015, $19000.0 in Q4 2014, and $58000.0 in Q4 2013.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	36.40 Mn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	5.08 Mn
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	-
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	2.72 Mn
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	92,219.00
10	Macrogenics	268.22 Mn	201.71 Mn	-	980,613.00

Download Data